MILTENYI BIOTEC GMBH
- Country
- Germany
- Type
- Beneficiary
- Website
- www.miltenyibiotec.com
- Grants received
- 34
Funding record
- 34 grants on record
- €9,044,883.45 awarded in total
- 2008–2024 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
17 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
- MILTENYI BIOTEC BV & CO KG
- CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS
- ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
- MEDIZINISCHE HOCHSCHULE HANNOVER
- ACADEMISCH ZIEKENHUIS LEIDEN
- MEDIZINISCHE UNIVERSITAET WIEN
- THE UNIVERSITY OF EDINBURGH
Calls from this organisation
No published calls from this organisation.
Grants received
- Plasma Medicine against Actinic Keratosis
- The GEne Therapy INnovation Training Network
- Human Gonad Developmental Cell Atlas
- TRAIN-HEART
- RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients
- Quantitative detection of bacterial endotoxin by novel nanotechnological approaches
- Interdisciplinary training network for advancing Organ-on-a-chip technology in Europe
- MAnufacturing of TUmour-REactive Natural Killer cells
- Transfer of multivirus-specific T-cells following transplantation
- Silicon Nitride Photonic Integrated Circuit Pilot line for Life Science Applications in the Visible Range
- DevelopIng Genetic medicines for Severe Combined Immunodeficiency (SCID)
- Chimeric Antigen Receptors (CARs) for Advanced Therapies
- Professional cross-priming for ovary and prostate cancer
- Upscaling human insulin-producing beta cell production by efficient differentiation and expansion of endoderm progenitors
- The impact of chromosomal instability on health: Molecular causes and consequences of aneuploidy
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.